Reply to: "The time is ripe for a randomized controlled trial of oral vancomycin in Primary Sclerosing Cholangitis"
Standard
Reply to: "The time is ripe for a randomized controlled trial of oral vancomycin in Primary Sclerosing Cholangitis". / Zigmond, Ehud; Schramm, Christoph.
In: CLIN GASTROENTEROL H, Vol. 21, No. 10, 09.2023, p. 2700.Research output: SCORING: Contribution to journal › Letter › Research › peer-review
Harvard
Zigmond, E & Schramm, C 2023, 'Reply to: "The time is ripe for a randomized controlled trial of oral vancomycin in Primary Sclerosing Cholangitis"', CLIN GASTROENTEROL H, vol. 21, no. 10, pp. 2700. https://doi.org/10.1016/j.cgh.2022.12.032
APA
Zigmond, E., & Schramm, C. (2023). Reply to: "The time is ripe for a randomized controlled trial of oral vancomycin in Primary Sclerosing Cholangitis". CLIN GASTROENTEROL H, 21(10), 2700. https://doi.org/10.1016/j.cgh.2022.12.032
Vancouver
Zigmond E, Schramm C. Reply to: "The time is ripe for a randomized controlled trial of oral vancomycin in Primary Sclerosing Cholangitis". CLIN GASTROENTEROL H. 2023 Sep;21(10):2700. https://doi.org/10.1016/j.cgh.2022.12.032
Bibtex
@article{aaee3d49fc7c41b4a0e152a975526525,
title = "Reply to: {"}The time is ripe for a randomized controlled trial of oral vancomycin in Primary Sclerosing Cholangitis{"}",
author = "Ehud Zigmond and Christoph Schramm",
year = "2023",
month = sep,
doi = "10.1016/j.cgh.2022.12.032",
language = "English",
volume = "21",
pages = "2700",
journal = "CLIN GASTROENTEROL H",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "10",
}
RIS
TY - JOUR
T1 - Reply to: "The time is ripe for a randomized controlled trial of oral vancomycin in Primary Sclerosing Cholangitis"
AU - Zigmond, Ehud
AU - Schramm, Christoph
PY - 2023/9
Y1 - 2023/9
U2 - 10.1016/j.cgh.2022.12.032
DO - 10.1016/j.cgh.2022.12.032
M3 - Letter
C2 - 36642293
VL - 21
SP - 2700
JO - CLIN GASTROENTEROL H
JF - CLIN GASTROENTEROL H
SN - 1542-3565
IS - 10
ER -
